MoonLake Immunotherapeut... Stock Quote MLTX - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

48.54

Bid

46.00

Ask

50.00

Volume

227,194

47.33 Day's Range 49.29

37.55 52 Week Range 64.98

Market Cap

3.102B

Previous Close

48.83

Open

48.80

Last Trade

49.13

Last Trade Time

16:29:27

Financial Volume

$ 11,119,636

VWAP

48.9434

Average Volume (3m)

315,088

Shares Outstanding

63,905,198

Dividend Yield

PE Ratio

-70.51

Earnings Per Share (EPS)

-0.69

Revenue

Net Profit

-44.08M

MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company engaged in leveraging Nanobody technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases. MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company engaged in leveraging Nanobody technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases.

Sector

Blank Checks

Industry

Pharmaceutical Preparations

Website

moonlaketx.com

Headquarters

Grand Cayman, Cym

Founded

2020

MoonLake Immunotherapeutics is listed in the Blank Checks sector of the NASDAQ with ticker MLTX. The last closing price for MoonLake Immunotherapeut... was $48.83. Over the last year, MoonLake Immunotherapeut... shares have traded in a share price range of $ 37.55 to $ 64.98.

MoonLake Immunotherapeut... currently has 63,905,198 shares outstanding. The market capitalization of MoonLake Immunotherapeut... is $3.12 billion. MoonLake Immunotherapeut... has a price to earnings ratio (PE ratio) of -70.51.

FeaturedAre we about to see a comeback? Steakholder Foods Charges Forward with New Commitments from Multiple International Players as it Transitions to Revenue Generation

FeaturedNorth Bay Resources Announces Production of Gold Concentrate and Refinery Shipment at Bishop Gold Mill, California

MoonLake Immunotherapeutics starts Phase 3 IZAR program of the Nanobody® sonelokimab in patients with active psoriatic arthritis

MoonLake Immunotherapeutics starts Phase 3 IZAR program of the Nanobody® sonelokimab in patients with active psoriatic arthritis Two trials for active psoriatic arthritis (PsA) with one focusing...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-3.46	-6.65384615385	52	54.81	48.3	238388	51.30942133	CS
4	-0.33	-0.675260896255	48.87	54.81	45.24	234290	48.91331069	CS
12	0.22	0.455298013245	48.32	56	44.71	315088	50.43126095	CS
26	8.93	22.5448119162	39.61	56	37.55	329457	46.45758206	CS
52	5.86	13.7300843486	42.68	64.98	37.55	399972	49.1949626	CS
156	36.17	292.400970089	12.37	64.98	4.25	350020	42.80486129	CS
260	36.17	292.400970089	12.37	64.98	4.25	350020	42.80486129	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
NCNCnoco noco Inc	$ 0.1493 (53.92%)	15.77M
SYMSymbotic Inc	$ 39.02 (27.68%)	796.41k
SMCXDefiance Daily Target 2X Long SMCI ETF	$ 31.47 (23.32%)	100.2k
PXSPyxis Tankers Inc	$ 4.82 (15.87%)	524
HCWBHCW Biologics Inc	$ 1.42 (14.52%)	3.51M
KLTOKlotho Neurosciences Inc	$ 0.3003 (-13.95%)	545.54k
UPXIUpexi Inc	$ 3.54 (-10.38%)	2.02k
GUREGulf Resources Inc	$ 0.59 (-9.92%)	944
GCTKGlucoTrack Inc	$ 0.26 (-9.72%)	26.51k
BNOXBionomics Ltd	$ 0.262 (-9.15%)	44.45k
NCNCnoco noco Inc	$ 0.1493 (53.92%)	15.77M
ELABElevai Labs Inc	$ 0.0222 (-3.06%)	10.12M
SMCISuper Micro Computer Inc	$ 24.28 (12.72%)	5.54M
NVDANVIDIA Corporation	$ 140.3499 (0.14%)	3.8M
HCWBHCW Biologics Inc	$ 1.42 (14.52%)	3.51M